Neurodiagnostic and monitoring devices are used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinsons disease, and ischemic stroke. These devices include equipment such as CT scanner, MRI scanner, PET scanner, and others.
Major factors that drive the neurodiagnostic and monitoring devices market include increase in prevalence of neurological disorders, ability of the devices to monitor patients in ICUs, sleep monitoring, ease of portability, and low cost of the devices in comparison to the other medical imaging tools. However, lack of skilled workers and limitations of EEGs in providing accurate diagnosis may impede the market growth. Surge in incidence of neurological disorders, technological developments, and increase in healthcare awareness among people may provide numerous opportunities for market expansion.
Get Free Sample Report :https://www.alliedmarketresearch.com/request-sample/2602
The neurodiagnostic and monitoring devices market is segmented on the basis of product, end user, and region. Products studied in the report include magnetoencephalography (MEG), electromyography (EMG), transcranial cerebral oximeters, electroencephalogram (EEG), cerebral oximeters, and intracranial pressure monitor. On the basis of end user, the market is divided into operation theatres, hospitals, clinics, and neurophysiological laboratories. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players operating in this market include Blackrock NeuroMed, Cadwell Laboratories, Compumedics, Delsys, Electrical Geodesic (EGI), Elmiko, LifeLines Neurodiagnostic Systems, MEG International Services, Motion Lab Systems, and Natus Medical.
